Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syncytial Virus Respiratory Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02114268
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI8897 in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
MedImmune LLC 342
Early research (Phase 1)Study completedNCT04520659
What this trial is testing

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID/ΔM2-2/1030s, in RSV-Seronegative Infants and Children 6 to 24 Months of Age

Who this might be right for
RSV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 81
Post-approval studies (Phase 4)Study completedNCT02571517
What this trial is testing

Glucocorticoid Therapy Impact on the Inflammatory Response and Clinical Evolution in Patients With Severe Bronchiolitis

Who this might be right for
Bronchiolitis, Viral
Fundació Sant Joan de Déu 94
Not applicableStudy completedNCT01915394
What this trial is testing

Respiratory Syncytial Virus Infection in Neonatal Intensive Care Units Throughout Turkey: Prospective Multicenter Study (TurkNICU-RSV Trial)

Who this might be right for
Respiratory Syncytial Virus InfectionsInfections, Epidemics
Ankara University 250
Large-scale testing (Phase 3)Study completedNCT06551181
What this trial is testing

A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 2,620
Early research (Phase 1)Study completedNCT06033612
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Food Effect Study of RV299 in Healthy Adults

Who this might be right for
Respiratory Syncytial Virus Infections
Pfizer 50
Early research (Phase 1)Study completedNCT01801293
What this trial is testing

Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806

Who this might be right for
RSV Infection
Gilead Sciences 8
Testing effectiveness (Phase 2)Study completedNCT05568706
What this trial is testing

EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 187
Testing effectiveness (Phase 2)Study completedNCT02254421
What this trial is testing

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract

Who this might be right for
Respiratory Syncytial Virus Infection
Gilead Sciences 60
Testing effectiveness (Phase 2)Study completedNCT03529773
What this trial is testing

Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults

Who this might be right for
Respiratory Tract Infections
Pfizer 1,235
Early research (Phase 1)Study completedNCT05585632
What this trial is testing

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old

Who this might be right for
SARS-CoV-2InfluenzaRSV
ModernaTX, Inc. 392
Not applicableStudy completedNCT05070975
What this trial is testing

Severity of RSV Infections in Twins

Who this might be right for
RSV InfectionBronchiolitis
Hospices Civils de Lyon 94
Testing effectiveness (Phase 2)Ended earlyNCT06999603
What this trial is testing

Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection

Who this might be right for
Viral Pneumonia
Synairgen Research Ltd. 11
Large-scale testing (Phase 3)Looking for participantsNCT06775405
What this trial is testing

Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants

Who this might be right for
Respiratory Synctial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 180
Early research (Phase 1)Study completedNCT03227029
What this trial is testing

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 65
Not applicableNot Yet RecruitingNCT07417657
What this trial is testing

Gut Microbiome and Immune Response in Severe RSV Infection in Vietnamese Infants

Who this might be right for
Respiratory Syncytial Virus InfectionBronchiolitisViral Lower Respiratory Tract Infection (LRTI)
Phuc Huu Phan 250
Early research (Phase 1)Study completedNCT06583031
What this trial is testing

Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years

Who this might be right for
RSV InfectionhMPV
Sanofi Pasteur, a Sanofi Company 385
Testing effectiveness (Phase 2)Study completedNCT03382431
What this trial is testing

PC786 to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of Multiple Doses in an RSV Challenge Study

Who this might be right for
Respiratory Syncytial Virus Infections
Pulmocide Ltd 56
Not applicableEnrolling By InvitationNCT06401720
What this trial is testing

Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection

Who this might be right for
Influenza A InfectionInfluenza B Virus InfectionSARS CoV 2 Infection+1 more
Karolinska Institutet 800
Large-scale testing (Phase 3)Study completedNCT05071313
What this trial is testing

An Ad26.RSV.preF-based Vaccine and High-dose Seasonal Influenza Vaccine, With and Without Coadministration, in Adults Aged 65 Years and Older

Who this might be right for
Influenza, Human PreventionRespiratory Syncytial Viruses Prevention
Janssen Vaccines & Prevention B.V. 777
Next Page